Selene Therapeutics Ltd. has identified brain permeable dihydroorotate dehydrogenase (DHODH) inhibitors reported to be useful for the treatment of epilepsy, cancer, Alzheimer’s disease, rheumatoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback